Clinical Trials

Study Title:
A Phase 3 Randomized Study Comparing Talquetamab in Combination With Daratumumab (SC) and Pomalidomide (Tal-DP) or Talquetamab (SC) in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone (DPd), in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received at Least 1 Prior Line of Therapy

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Kimberly Green, at greekm@musc.edu. Study Coordinator, Hana Baker, at bakerhan@musc.edu. Trial opened at the following institutions: Medical University of South Carolina